LB Pharmaceuticals, Inc. (LBRX)
28.49
+0.10
(+0.35%)
USD |
NASDAQ |
Jun 11, 12:59
LB Pharmaceuticals Price to Book Value : 2.157 for June 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 2.150 |
| June 09, 2026 | 2.216 |
| June 08, 2026 | 2.226 |
| June 05, 2026 | 2.160 |
| June 04, 2026 | 2.188 |
| June 03, 2026 | 2.116 |
| June 02, 2026 | 2.046 |
| June 01, 2026 | 2.122 |
| May 29, 2026 | 2.118 |
| May 28, 2026 | 2.085 |
| May 27, 2026 | 2.105 |
| May 26, 2026 | 2.145 |
| May 22, 2026 | 2.129 |
| May 21, 2026 | 2.120 |
| May 20, 2026 | 2.123 |
| May 19, 2026 | 2.065 |
| May 18, 2026 | 2.101 |
| May 15, 2026 | 2.246 |
| May 14, 2026 | 2.378 |
| May 13, 2026 | 2.447 |
| May 12, 2026 | 2.357 |
| May 11, 2026 | 2.476 |
| May 08, 2026 | 2.421 |
| May 07, 2026 | 2.422 |
| May 06, 2026 | 2.423 |
| Date | Value |
|---|---|
| May 05, 2026 | 2.490 |
| May 04, 2026 | 2.410 |
| May 01, 2026 | 2.38 |
| April 30, 2026 | 2.401 |
| April 29, 2026 | 2.316 |
| April 28, 2026 | 2.376 |
| April 27, 2026 | 2.409 |
| April 24, 2026 | 2.327 |
| April 23, 2026 | 2.330 |
| April 22, 2026 | 2.406 |
| April 21, 2026 | 2.406 |
| April 20, 2026 | 2.398 |
| April 17, 2026 | 2.311 |
| April 16, 2026 | 2.141 |
| April 15, 2026 | 2.205 |
| April 14, 2026 | 2.012 |
| April 13, 2026 | 1.926 |
| April 10, 2026 | 1.843 |
| April 09, 2026 | 1.991 |
| April 08, 2026 | 1.967 |
| April 07, 2026 | 1.916 |
| April 06, 2026 | 2.040 |
| April 02, 2026 | 1.945 |
| April 01, 2026 | 1.879 |
| March 31, 2026 | 1.867 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| NRX Pharmaceuticals, Inc. | -- |
| Alto Neuroscience, Inc. | 2.957 |
| ANI Pharmaceuticals, Inc. | 3.328 |
| Corcept Therapeutics, Inc. | 13.70 |
| Assertio Holdings, Inc. | 2.001 |
Price to Book Value Related Metrics
| Price | 28.49 |
| Earnings Yield | -5.21% |
| Market Cap | 816.95M |